The efflux pump AcrAB is important in the antibiotic resistance and virulence of several pathogenic bacteria. We report that deletion of the Yersinia pestis AcrAB-TolC homolog leads to increased susceptibility to diverse substrates, including, though unlike in Escherichia coli, the aminoglycosides. Neither is the Y. pestis pump affected by the efflux pump inhibitor phenylalanine-arginine beta-naphthylamide. In mouse plague models, pump deletion does not have a significant effect on tissue colonization.
not take into account changes in susceptibility brought about by membrane perturbation resulting from the absence of pump components. Increased susceptibility to the aminoglycosides was unexpected, as this antibiotic class is not a substrate for the Escherichia coli AcrAB-TolC pump (24) , although it is a substrate for the homologous Pseudomonas aeruginosa and Klebsiella pneumoniae complexes (25, 27) . A ClustalW alignment of AcrB pri- In all instances, deletion caused major increases in drug susceptibility. a, norfloxacin and ciprofloxacin MICs could not be shown for the tolC and acrAB strains, as the boundary of bacterial growth was below the lowest antibiotic concentration of the Etest strip. Asterisks denote significance as calculated by one-way ANOVA with Tukey's posttest, as follows: ‫,ء‬ P value of 0.01 to 0.05; ‫,ءء‬ P value of 0.001 to 0.01; ‫,ءءء‬ P value of Ͻ0.001. AMP, ampicillin; CHL, chloramphenicol; CIP, ciprofloxacin; DOX, doxycycline; GMC, gentamicin; KAN, kanamycin; NAL, nalidixic acid; NOR, norfloxacin; RIF, rifampin; SMC, streptomycin; TET, tetracycline; TMS, trimethoprimsulfamethoxazole. mary sequences from E. coli, Y. pestis, and P. aeruginosa showed no obvious reason why AcrAB-TolC from Y. pestis should efflux aminoglycosides (data not shown).
Bacteria entering host organisms such as humans and rodents use defenses against antimicrobial peptides which are secreted by epithelial cells as part of the innate immune response and by other resident bacteria (2, 5, 12, 13, 17) . We used polymyxin B (PMB), as a representative antimicrobial peptide, and determined the susceptibility of Y. pestis using plate dilution assays (14) , taking the average of at least 3 experiments. The MICs for PMB of the WT (350 g/ml), acrAB (80 g/ml), and tolC (0.35 g/ml) strains suggest that while PMB is a substrate for AcrAB, the dramatic increase in susceptibility with a tolC deletion (0.4% of the AcrAB MIC [ Table 1 ]) indicates that TolC likely acts as the exit duct for other pumps associated with PMB efflux. In E. coli, the PMB MIC is far lower (0.03 g/ml) and only 50% lower than that of the WT for both the acrAB and the tolC deletion mutants (40) . As for the antibiotic MICs, these findings suggest that the related pumps of different bacterial species may have different substrate affinities.
Enteric pathogens must survive passage through bile in the small intestine. Bile is a substrate of AcrAB-TolC in E. coli, V. cholerae, F. tularensis, and S. enterica (3, 6, 23, 36) . We used plate dilution assays (14) with OxGall (Sigma) to determine the MICs of Y. pestis WT, acrAB, and tolC strains as Ͼ9 mg/ml, 1.5 mg/ml, and 0.35 mg/ml, respectively. As for PMB, these findings show that Y. pestis AcrAB is not the only bile efflux pump, as the tolC deletion mutant causes a further increase in susceptibility. In contrast to PMB, this finding compares well with the E. coli TolC pumps, where bile salts are the substrates of several pumps as well as AcrAB-TolC and deletion of tolC increases susceptibility above that of the acrB or acrAB deletion strains (35) .
It has been shown that deletion of tolC results in an increase in the levels or activity of the transcriptional regulators MarA, SoxS, and Rob (32) . Porins are among the many genes that are regulated by these transcription factors (1, 31) . It is highly probable that the loss of AcrAB-TolC induces changes in membrane permeability beyond simply loss of efflux which may also affect susceptibility.
Multidrug-resistant clinical strains show a high frequency of mutations in efflux pump genes (8, 15, 21, 22, 39, 41) . Dual therapy involving treatment with an antibiotic and an efflux pump inhibitor (EPI) is proposed as a way to restore the efficacy of the antibiotic in resistant strains. We used the broad-spectrum EPI phenylalanine-arginine ␤-naphthylamide (PA␤N), a potentiator of susceptibility to chloramphenicol, tetracycline, macrolides, fluoroquinolones, and aminoglycosides (4, 10, 16) , to determine if this would increase the susceptibility of Y. pestis to antibiotics. Etest studies on plates with and without 20 g/ml of PA␤N showed that WT susceptibility to nalidixic acid and rifampin in- creased only by ϳ50%. Susceptibility to other antibiotics was not affected. For comparison, we tested the effect of PA␤N on the drug susceptibility of the E. coli MG1655 strain and found a 77 to 96% increase in susceptibility for chloramphenicol, nalidixic acid, and rifampin ( Table 2) . These findings are similar to results reported previously (33) . For norfloxacin, ciprofloxacin, streptomycin, and ampicillin, there was, in fact, an unexpected decrease in susceptibility of E. coli in the presence of PA␤N (Table 2) . Etests on the acrAB and tolC strains showed increases in susceptibility to tetracycline, nalidixic acid, chloramphenicol, and rifampin (50 to 75% [ Table 2 ]) in the presence of PA␤N, suggesting that PA␤N is effluxed by AcrAB in the WT strain, and with the loss of the pump in the deletion strains, PA␤N is able to inhibit other pumps. Further, unlike WT Y. pestis, acrAB or tolC strains were not able to grow at 50 or 100 g/ml PA␤N, suggesting that in the absence of AcrAB or TolC, PA␤N is lethal.
Together, these findings suggest that Y. pestis AcrAB-TolC plays a role in efflux of PA␤N but is minimally inhibited by it. In contrast, the E. coli AcrAB pump and the P. aeruginosa MexAB pump efflux PA␤N but are also inhibited by it (4, 20, 21, 42) .
As there is a slight but significant decrease in the susceptibility of certain antibiotics in the presence of PA␤N (ciprofloxacin, norfloxacin, and streptomycin), checkerboard assays were performed with E. coli MG1655 at 5 ϫ 10 5 CFU/ml in 96-well microtiter plates. A series of 7 twofold dilutions were made such that the MIC of the antibiotic in question was approximately the median concentration of the series. A series of 7 twofold dilutions of PA␤N was also made, the highest concentration being 80 g/ml and the lowest in the series being 1.25 g/ml. FIC thresholds used were Յ0.5 to denote synergy, Ͼ0.5 to Յ4 to denote indifference, and Ͼ4 to denote antagonism. Three separate checkerboard assays were performed. FICs were calculated as the sum of the combination MIC divided by the MIC for each compound and are shown in Table 3 . Synergy was found for nalidixic acid, and indifference was found for ciprofloxacin. MIC values were higher overall in the microtiter format then by Etest, and this difference was more marked for ciprofloxacin than for nalidixic acid but the trend of decreased susceptibility in the presence of PA␤N for ciprofloxacin and increased susceptibility of nalidixic acid held. These data support our Etest findings. A literature search was done to compare our findings with those of other studies, particularly with regard to fluoroquinolones, as the initial study on PA␤N on P. aeruginosa (21) saw an 8-fold increase in susceptibility to fluoroquinolone and levofloxacin. Other studies show that the effect of PA␤N is dependent on strain and antibiotic (4, 29, 33) for both E. coli and P. aeruginosa and that the fold increase in susceptibility varies from 1 to 8. Pasquali and Manfreda (29) also show that E. coli strain ATCC 25922 had MICs of 0.016 to Ͻ0.06 g/ml in the absence and presence of 80 g/ml PA␤N. This shows that there is variation between strains as to the effect on PA␤N and that our findings do not contradict the findings from other groups.
Since the homologs of the AcrAB-TolC pump in other pathogens are important in virulence (3, 27, 30) , we studied the contribution of acrAB in organ colonization in pneumonic and septicemic models of plague and the contribution of tolC in the pneumonic plague model. Seven-to 8-week-old female BALBc mice were infected intranasally or intravenously with 20 and 10 times the 50% lethal dose (LD 50 ), respectively (28, 38) . Four (intravenous) or 5 (intranasal) days postinfection, mice were euthanized; tissues were harvested, homogenized, serially diluted, and plated for CFU. Strikingly, no difference was seen for the tolC strain (results not shown). While a trend toward lower colonization levels by the acrAB mutant was observed, it was not significant (Fig. 2) . These findings suggest that unlike in other pathogens, Y. pestis AcrAB does not play a significant role in establishing infections in pneumonic or septicemic plague in mice.
